FTC Investigates Hims & Hers Over Subscription Cancellation Complaints

The U.S. Federal Trade Commission (FTC) is currently investigating Hims & Hers, a leading telehealth platform, over consumer complaints related to its advertising and subscription cancellation practices. Multiple reports indicate that the FTC has launched an inquiry following a surge in user concerns about the company’s handling of its subscription model [1]. Hims & Hers has confirmed it is cooperating with the agency, though it has not revealed specifics about the allegations under review [2].

The probe centers on whether Hims & Hers is violating consumer protection laws by potentially misleading users or creating unnecessary barriers to canceling subscriptions. These practices have drawn increasing regulatory scrutiny across the digital health sector, particularly as companies expand their online offerings and customer engagement strategies [1]. The FTC’s focus on subscription complexity and transparency reflects broader concerns about user experience in the digital age.

The news has already had a visible impact on Hims & Hers Health, Inc.’s stock price. Reports indicate a drop in the company’s shares after the probe was first reported, raising questions among investors and analysts about the potential implications for its business operations and consumer trust [3]. Social media platforms have amplified the conversation, with traders and observers commenting on how the investigation might affect the company’s market position and brand reputation [4].

As the investigation continues, Hims & Hers remains a major player in the telehealth industry, offering a variety of health products and services. The outcome of this case could influence how regulators assess similar businesses, especially in relation to advertising transparency and subscription management. With no official statements yet from the FTC or the company on the findings or next steps, the situation remains fluid.

Source:

[1] Bloomberg.com (https://www.bloomberg.com/news/articles/2025-08-14/ftc-probing-complaints-about-hims-ads-cancellation-practices)

[2] Investing.com (https://ca.investing.com/news/stock-market-news/hims--hers-health-stock-drops-after-ftc-probe-report-surfaces-4160682)

[3] StreetInsider (https://www.streetinsider.com/Trader+Talk/Hims+%26+Hers+Health%2C+Inc.+%28HIMS%29+Probed+By+US+FTC+Over+Cancellation+Practices+-+Bloomberg/25206133.html)

[4] X (https://x.com/wallstengine/status/1956084467199828013)